TEXAS A&M UNIVERSITY Many cancer patients suffer from a loss of body mass known as cachexia. Approximately 20 percent of cancer-related deaths are attributed to the syndrome of cachexia, which in cancer patients is often characterized by a rapid or severe loss of fat and skeletal muscle. Dr. Melinda Sheffield-Moore, professor and head of the...
Tag: <span>Anti-Cancer</span>
Post
Killer Immunotherapy—fighting cancer with genetic engineering
July 17, 2018 by Teresa Belcher, Particle Finding a cure for cancer is no easy feat, but Dr. Misty Jenkins has built her career in immunotherapy to do just that. Since 2016, Misty has led a lab at the Walter and Eliza Hall Institute of Medical Research. From a young age, Misty was fascinated with how the...
Post
Some existing anti-cancer drugs may act in part by targeting RNA, study shows
SCRIPPS RESEARCH INSTITUTE JUPITER, FL – June 28, 2018 – Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti-cancer drugs may work, in part, by binding tightly to RNA, the regulators of the basic activities of life within cells. The research offers another approach for tackling diseases...
Post
New immunotherapy for lung cancer shows promise of success
In a groundbreaking development, results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination is surprisingly effective at controlling the disease’s progression. The study, published April 4 in the journal The Lancet Oncology, focused on non-small cell lung cancer, which is the most common form of lung cancer. IMAGE: In...
Post
How a novel protein may combat cancer
Breaking research published in the journal Nature describes a new anti-cancer protein. The finding could help to spot cancer earlier and treat it more effectively. Using cuting edge techniques, Swiss researchers find a new cancer-fighting protein. Each year, around 31,000 people in the United States develop liver cancer, also known as hepatocellular carcinoma . And, roughly...
Post
Medication that treats parasite infection also has anti-cancer effect
Overview of In vivo pooled library screen of new therapeutic targets for human epithelial ovarian cancer : This is the diagram depicting the overview of in vivo loss-of-function library screens. First, human ovarian cancer cell line was lentivirally transduced with druggable pooled shRNA library or whole-genome CRISPR/Cas9 library, generating large pool of cells with knockdown...
Post
Molecule identified that helps give resident T cells in the skin their anti-cancer punch
Mouse showing signs of vitiligo. Photograph courtesy of Medical University of South Carolina cancer immunologist Dr. Chrystal M. Paulos and Dartmouth’s Dr. Mary Jo Turk. The molecule CD103 is key to the long-term residence of T cells in the skin and to their anti-tumor function, report a team of researchers at the Medical University...